The Ekhaga Foundation, Stockholm, Sweden   Report issue

Foundation Phase 2
Founded: Stockholm Sweden (1999)

Organization Overview

First Clinical Trial
2001
NCT01285830
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Ekhaga foundation | The Ekhaga Foundation, Sweden

Active Ingredients

Drugs in Phase 2 Trials (1)

lactobacillus reuteri (2 trials)

Drugs in Other Trials (4)

gluten (1 trial)

icosapent ethyl (vascepa) (1 trial)

soybean oil (Intralipid) (1 trial)

zhineng qigong (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Birth Weight (Phase 2)

Enterocolitis (Phase 2)

Enterocolitis, Necrotizing (Phase 2)

Failure to Thrive (Phase 2)

Premature Birth (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 5